Schedule an Appointment
Inflammation Support

Physician-guided support for recovery, repair, and inflammation control.

TransformRX offers personalized peptide protocols designed to support soft-tissue healing, joint and muscle recovery, gut and skin inflammation, immune regulation, and cellular resilience. Depending on clinical appropriateness, a plan may include BPC-157, TB-500/TB-4, Wolverine Blend, MOTS-C, GHK-Cu, KPV, or Thymosin Alpha-1.

Schedule a Consultation
Physician-guided inflammation and recovery support at TransformRX
Recovery Focused Personalized care for tissue repair, inflammation control, and whole-body recovery.
Understanding Inflammation

Inflammation can affect recovery throughout the body.

Inflammation is part of the body's normal response to injury and stress, but when it becomes persistent or poorly regulated it may contribute to pain, stiffness, delayed recovery, gut irritation, skin symptoms, and reduced physical performance. A thoughtful evaluation helps determine whether peptide therapy is appropriate and which pathway should be targeted.

Repair

Soft-Tissue Recovery

BPC-157 and TB-500/TB-4 are associated with tendon, ligament, muscle, and wound-recovery support.

Balance

Inflammatory Signaling

KPV, GHK-Cu, and Thymosin Alpha-1 may be considered in protocols focused on inflammatory and immune regulation.

Energy

Cellular Resilience

MOTS-C is studied for mitochondrial energy metabolism, insulin sensitivity, and stress adaptation.

Potential Areas of Support

Care designed around your recovery goals.

Depending on your evaluation, a personalized protocol may focus on one or more of the following:

Tendon & Ligament Recovery

Support for slow-healing connective tissues and injury recovery.

Muscle & Joint Recovery

Support for mobility, flexibility, soreness, and return to activity.

Gut Barrier Support

BPC-157 and KPV are used in protocols focused on gut-lining support.

Skin & Wound Repair

Support for tissue remodeling, collagen, and skin-barrier recovery.

Immune Modulation

Support for balanced immune signaling and T-cell function.

Metabolic Resilience

Support for mitochondrial function, energy metabolism, and stress adaptation.

Different Recovery Pathways

Different therapies support different stages of repair.

Inflammation-focused therapies do not all work the same way. Some are associated with local tissue repair, others with systemic cell migration, immune modulation, collagen remodeling, gut and skin barrier support, or mitochondrial resilience.

Localized Repair Signaling

BPC-157 is associated with angiogenesis, collagen synthesis, growth-factor signaling, and repair of tendons, ligaments, muscles, and the gastric lining.

Systemic Cell Migration

TB-500/TB-4 supports cell migration, flexibility, angiogenesis, and tissue remodeling throughout the body.

Immune & Barrier Regulation

KPV and Thymosin Alpha-1 are used in protocols focused on inflammatory signaling, immune balance, and barrier support.

Personalized recovery and inflammation consultation at TransformRX
Inflammation Support Options

Explore the therapies in this support category.

These therapies are not interchangeable. Their evidence, administration, regulatory status, and suitability vary. A TransformRX clinician determines which option, if any, is appropriate.

Local Repair

BPC-157

BPC-157 is a gastric-derived peptide associated with tissue repair and anti-inflammatory signaling. It is used in recovery protocols for soft-tissue healing, gut support, pain modulation, and tendon- or ligament-related concerns.

Potential BenefitsSoft-tissue healing, gut support, pain modulation, and inflammatory support.
How It May WorkAssociated with angiogenesis, growth-factor signaling, blood flow, and collagen synthesis.
Common RoutesUsually subcutaneous; sometimes oral depending on formulation and protocol.
Systemic Recovery

TB-500 / TB-4

TB-500 is a synthetic fragment related to Thymosin Beta-4. It is involved in tissue remodeling and is used in protocols focused on wound healing, angiogenesis, tendon recovery, and systemic musculoskeletal support.

Potential BenefitsCell migration, tissue flexibility, wound healing, and recovery support.
How It May WorkRegulates actin-related cell movement, helping repair cells reach injured tissues.
Common RoutesUsually subcutaneous or intramuscular in clinician-directed protocols.
Combination Protocol

Wolverine Blend

The Wolverine Blend typically combines BPC-157 with TB-500 or TB-4. The pairing is designed to combine more localized growth-factor and collagen signaling with broader systemic cell migration and tissue-remodeling support.

Potential BenefitsMusculoskeletal healing, injury recovery, mobility, and regeneration support.
Why They Are CombinedBPC-157 is positioned as more localized, while TB-500 acts more systemically.
Common RouteTypically administered as a subcutaneous injection.
Mitochondrial Support

MOTS-C

MOTS-C is a mitochondrial-derived peptide being studied for its potential to support metabolic function, cellular energy production, insulin sensitivity, and stress adaptation.

Potential BenefitsEnergy metabolism, insulin sensitivity, fatigue support, and cellular resilience.
How It May WorkAssociated with regulation of mitochondrial activity and metabolic adaptation.
Common RouteTypically administered subcutaneously.
Regenerative Copper Peptide

GHK-Cu

GHK-Cu is a naturally occurring copper-binding tripeptide involved in wound healing, tissue regeneration, collagen production, skin remodeling, and inflammatory control.

Potential BenefitsSkin rejuvenation, collagen and elastin support, hair support, wound healing, and inflammation control.
How It May WorkForms a copper-peptide complex with regenerative properties and broad gene-expression effects.
Common RoutesTopical or subcutaneous depending on the treatment goal.
Anti-Inflammatory Peptide

KPV

KPV is an alpha-MSH fragment with anti-inflammatory properties. It is used in protocols focused on gut and skin inflammation, overactive immune signaling, and barrier-tissue support.

Potential BenefitsGut and skin anti-inflammatory support and barrier-tissue support.
Clinical PositioningOften considered in dermatitis- and IBD-adjacent wellness protocols.
Common RoutesOral, topical, or subcutaneous depending on formulation.
Immune Modulation

Thymosin Alpha-1

Thymosin Alpha-1 is an immune-modulating thymic peptide associated with immune support and T-cell regulation. It is used in protocols focused on immune dysfunction and infection-related support.

Potential BenefitsImmune support, T-cell modulation, and inflammatory-balance support.
How It May WorkActs through thymic and immune-signaling pathways involved in adaptive immune response.
Common RouteTypically administered subcutaneously.
BPC-157 / TB-500 Recovery Timeline

What patients may notice over time.

The following timeline is based on the TransformRX BPC-157/TB-500 patient guide. Individual responses vary.

1–7 Days

Early inflammatory signaling may begin to shift, and some patients report less acute soreness or discomfort.

7–21 Days

During the proliferation phase, collagen and fibroblast activity may support improved mobility, flexibility, and reduced stiffness.

3–8 Weeks

Tissue remodeling may support stronger repaired structures, less scar-tissue formation, and a more complete return to activity.

Which Therapy May Align With Your Goals?

Matching the option to the recovery goal.

This comparison is educational only. Final selection depends on your medical history, symptoms, contraindications, and clinician assessment.

Goal Therapies Commonly Considered Primary Area of Support
Tendon, Ligament & Muscle RecoveryBPC-157, TB-500/TB-4, Wolverine BlendCollagen signaling, angiogenesis, cell migration, tissue remodeling
Gut & Skin InflammationBPC-157, KPV, GHK-CuBarrier support, inflammatory signaling, tissue repair
Wound & Skin RemodelingGHK-Cu, TB-500/TB-4, Wolverine BlendCollagen, elastin, cell migration, wound healing
Immune RegulationThymosin Alpha-1, KPVT-cell modulation and inflammatory balance
Metabolic & Cellular ResilienceMOTS-CMitochondrial function, energy metabolism, stress adaptation
The TransformRX Process

Your recovery plan is built through medical guidance.

Pain and inflammation may have many causes, including acute injury, repetitive strain, autoimmune disease, infection, gut disorders, or other medical conditions. Peptide therapy does not replace proper diagnosis, imaging, rehabilitation, or standard medical care.

1. Comprehensive Consultation

Review the injury, symptoms, health history, medications, and recovery goals.

2. Clinical Assessment

Relevant imaging, laboratory testing, rehabilitation needs, and contraindications may be reviewed.

3. Personalized Protocol

Your clinician selects an appropriate therapy, route, schedule, and monitoring plan.

4. Ongoing Monitoring

Progress, pain, mobility, tolerance, and functional recovery are reassessed over time.

Safety & Regulatory Considerations

Physician supervision is essential.

Many peptides discussed on this page are investigational, compounded, or used off-label. Long-term safety and efficacy data may be limited, and compounded products are not FDA-approved finished drug products. Eligibility should be determined through appropriate screening, informed consent, and monitoring.

Do not self-adjust treatment: Doses and schedules should only be changed by your clinician.

Contraindications matter: Pregnancy, breastfeeding, cancer, hypersensitivity, Wilson's disease, and other conditions may affect eligibility depending on the therapy.

Urgent symptoms need standard care: Fever, rapidly increasing swelling, severe weakness, neurologic symptoms, or suspected infection require prompt medical evaluation.

Inflammation Support FAQs

Common questions, clearly answered.

BPC-157 is generally positioned as more localized and is associated with angiogenesis, collagen synthesis, and growth-factor signaling. TB-500 acts more systemically by supporting cell migration, flexibility, angiogenesis, and tissue remodeling.
Wolverine Blend is the common name for a combination of BPC-157 and TB-500 or TB-4. It is designed to combine localized tissue repair signaling with broader systemic recovery support.
BPC-157, KPV, and GHK-Cu are commonly discussed in protocols involving gut-barrier, skin-barrier, inflammatory, and regenerative support. The right choice depends on the clinical goal and formulation.
Timelines vary by injury, severity, therapy, rehabilitation, overall health, and individual response. The TransformRX BPC-157/TB-500 guide describes early changes during the first week, proliferation during weeks one to three, and remodeling over approximately three to eight weeks.
No. Peptide therapy does not replace proper diagnosis, imaging, physical therapy, surgery, or other standard care when those are indicated. It may be considered as one part of a broader clinician-directed recovery plan.
Administration varies by therapy. Common routes include subcutaneous injection, intramuscular injection, oral formulations, and topical products. Exact instructions are provided by the prescribing clinician.
A clinician may consider a combination when medically appropriate, but protocols should not be selected from a website list alone. Potential overlap, contraindications, formulation, and monitoring needs must be reviewed.
Getting Started

Begin with a thoughtful recovery evaluation.

Schedule Your Consultation

Meet with the TransformRX team to discuss your symptoms, injury history, recovery goals, previous treatment, and whether a physician-guided peptide protocol may be appropriate.

Prepare for Your Visit

Bring relevant imaging, operative reports, physical-therapy notes, current medications and supplements, and details about when the symptoms began and what makes them better or worse.

Personalized Recovery Support

Recover with a plan built around you.

Schedule a consultation to explore physician-guided options for inflammation control, tissue repair, immune support, and functional recovery.

Schedule a Consultation

Important Clinical Notice

The information on this page is for education only and is not a diagnosis or treatment recommendation. Many peptides discussed here are investigational, compounded, or used off-label and may not be FDA-approved for the goals described. Availability and eligibility are determined through physician evaluation, informed consent, and ongoing monitoring.